Conversely, in RBE, the CCA cell line, was deemed ‘resistant’ because it had no significant changes in IC markers after MYC inhibition or knockdown, which did not potentiate immune-mediated cell death. This evidence concerns the gene MYC and cholangiocarcinoma.